| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0009 | 1 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.00054 | 1 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.00017 | 1 |